Novel Symptom Subgroups in Patients With Irritable Bowel Syndrome Are Associated With Healthcare Utilisation in Secondary and Tertiary Care
Alimentary Pharmacology & Therapeutics · 2026
DOI: 10.1111/apt.70583 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2026. Verfasst von Vivek C Goodoory und 12 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Patient Acceptance of Health Care, Tertiary Health Care. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background & Aims Current classification systems for irritable bowel syndrome (IBS) based on bowel habit do not consider psychological impact. We applied a previously validated latent class analysis (LCA) model to a cohort of patients with IBS in secondary and tertiary care to assess whether it predicted levels of healthcare utilisation.
Methods
We applied our LCA model to a referral population with IBS. As described previously, we assigned cluster membership based on gastrointestinal symptom severity and psychological burden. We assessed demographics, symptom severity and quality of life at baseline and levels of healthcare utilisation during 12 months of longitudinal follow‐up according to cluster.
Results
We recruited 379 patients, of whom 249 (65.7%) met the Rome IV criteria. Those in the four clusters with higher psychological burden had more severe symptoms on the IBS‐SSS and lower quality of life scores ( p < 0.001 for both). Rates of discharge were generally lower in clusters with higher psychological burden ( p = 0.05). Rates of prescribing a drug for IBS ( p = 0.001), the mean number of drugs prescribed for IBS ( p < 0.001) and the mean number of different drug types prescribed for IBS ( p < 0.001 for trend) were highest in the four clusters with higher psychological burden.
Conclusions
In patients with IBS in secondary and tertiary care, the LCA model identified groups of individuals with more severe symptoms and greater impairments in quality of life at baseline and significantly higher rates of healthcare utilisation during longitudinal follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.
- Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
- Neurogastroenterology Unit, Wythenshawe Hospital, Gastrointestinal Medicine and Surgery, Manchester University NHS Foundation Trust, Manchester, UK.
- Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, UK.
- Department of Gastroenterology, Western General Hospital, Edinburgh, UK.
- Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
ORCID-Profile: Vivek C Goodoory, Imran Aziz, Maura Corsetti, Christopher J Black, Alexander C Ford
Zitieren
APA
Goodoory, V. C., Khasawneh, M., Riggott, C., Vasant, D. H., Eugenicos, M., Aziz, I., Corsetti, M., Paine, P. A., Danvers, R., McKinnie, K., Bush, D., Black, C. J., & Ford, A. C. (2026). Novel Symptom Subgroups in Patients With Irritable Bowel Syndrome Are Associated With Healthcare Utilisation in Secondary and Tertiary Care. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70583
Vancouver
Goodoory VC, Khasawneh M, Riggott C, Vasant DH, Eugenicos M, Aziz I, et al. Novel Symptom Subgroups in Patients With Irritable Bowel Syndrome Are Associated With Healthcare Utilisation in Secondary and Tertiary Care. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70583
BibTeX
@article{Goodoory2026,
author = {Goodoory, Vivek C and Khasawneh, Mais and Riggott, Christy and Vasant, Dipesh H and Eugenicos, Maria and Aziz, Imran and Corsetti, Maura and Paine, Peter A and Danvers, Ryan and McKinnie, Karen and Bush, Debbie and Black, Christopher J and Ford, Alexander C},
title = {Novel Symptom Subgroups in Patients With Irritable Bowel Syndrome Are Associated With Healthcare Utilisation in Secondary and Tertiary Care},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.70583}
}
EUVIMED